NICE final draft guidance recommends gene therapy for rare ‘bubble baby syndrome’
Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed “bubble baby syndrome” has been approved by NICE in final draft guidance.
Source: NHS Networks - Category: UK Health Source Type: news
More News: Babies | Gene Therapy | Genetics | National Institute for Health and Clinical Excelle | UK Health